Clinical Trials Logo
  1. Home
  2. Mammography
  3. NCT01124019

Single Nucleotide Polymorphism (SNP) Panels and Risk Assessment in Women Undergoing Mammography

Mammography Clinical Trial

Official title:
SNP Panels and Risk Assessment in Women Undergoing Mammography

Clinical Trial Summary

The primary objective is to compare the predicted lifetime risk values produced by SNP panel assessment to the risk values produced by the prediction models that are most commonly used. A second objective is to examine whether the incorporation of risk assessment panels (standard or SNP based) can improve the positive value of breast biopsies in women with BIRADS 4 mammograms.

Clinical Trial Description

Calculating the risk that a woman will develop breast cancer in her lifetime can lead to decreased mortality rates as a result of increased screening and prevention methods when a person is known to be at high risk. Though there are several risk assessment models that are commonly used, it is important to continue to improve the process of calculating risk. Several genetic markers have been noted to potentially indicate risk of developing breast cancer. New tests, called SNP panels, can detect some of these genetic markers. This study aims to use both these SNP panels and the commonly used risk models to calculate risk and examine outcomes in women coming in to do screening mammography. This study will enroll women between the ages of 40-65 who are undergoing screening mammography (n=1000), in addition to women with BIRADS category 4 mammogram readings who are about to undergo biopsy (n=600), all with no personal history of breast or ovarian cancer, ductal carcinoma in situ (DCIS), mantle radiation, or known BRCA 1/2/mutation in self or family members. The participants will only be expected rto provide consent, swabs of the inside of the cheek of her mouth, and baseline questionnaire answers that will allow for a risk assessment to be performed. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01124019
Study type Observational
Source Abramson Cancer Center of the University of Pennsylvania
Contact
Status Completed
Phase
Start date February 2010
Completion date October 2012
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04983875 - Mammography and Breast Arterial Calcification: An Information-Sharing Trial N/A
Recruiting NCT04904757 - Contrast-enhanced Spectral Mammography (CESM) Breast Cancer Screening N/A
Recruiting NCT05975736 - Searching for Masses and Calcifications at the Same Time in Breast Cancer Screening N/A
Withdrawn NCT03639129 - Improving Characterization of Calcifications With Contrast-Enhanced Mammography N/A
Completed NCT03684733 - Magnetic Resonance Breast Tissue Characterisation to Improve Risk Stratification for Breast Cancer
Completed NCT00827307 - Zoladex Plus Tamoxifen in Breast Cancer N/A
Completed NCT00724516 - Evaluation Of A Novel Breast Compression Paddle For Wire Localization In Mammography N/A
Completed NCT04009278 - Self-compression Mammography in Clinical Practice N/A
Recruiting NCT03857152 - Can Contrast Enhanced Spectral Mammography (CESM) Reduce the Number of Benign Biopsies for Calcifications Without Negatively Impacting on Detection/Diagnosis of Clinically Significant Calcifications N/A
Recruiting NCT05199701 - Prospective Case Collection Study for New Mammography Technologies N/A
Recruiting NCT05009277 - Study To Evaluate The Sensitivity Of The Linda Thermal Device
Completed NCT04741503 - Project Insight: Feasibility of a Breast Cancer Screening Decision Support Tool N/A
Not yet recruiting NCT06265207 - The Effect of Virtual Reality on Pain, Anxiety and Satisfaction Level Before Mammography N/A